Etiological Spectrum of Lymphadenopathy Among Children on Lymph Node Biopsy

Chandni Nawaz1, Mulazim Hussain2, Bilal Ahmad3

  • 1Pediatric Surgery, Children's Hospital, Pakistan Institute of Medical Sciences, Islamabad, PAK.

Cureus
|October 1, 2024
PubMed

Insights

Pediatric lymphadenopathy is often benign but can signal serious illness. This study found tuberculosis (TB) and lymphoma are the most common causes in children requiring biopsy, suggesting targeted diagnostics in endemic areas.

Area of Science:

  • Pediatric Infectious Diseases
  • Surgical Pathology
  • Oncology

Background:

  • Pediatric peripheral lymphadenopathy is frequently benign but can indicate severe underlying conditions.
  • Excisional biopsy is a key diagnostic tool for persistent lymphadenopathy in children.
  • Understanding the etiological spectrum is crucial for appropriate management in low-middle-income countries.

Purpose of the Study:

  • To determine the causes of persistent pediatric lymphadenopathy diagnosed via excisional biopsy.
  • To recommend optimized evaluation, diagnostic testing, and surgical interventions for this population.
  • To analyze the diagnostic utility of GeneXpert and PPD tests for tuberculosis.

Main Methods:

  • A prospective cross-sectional study of 243 pediatric patients (1-12 years) with lymphadenopathy >4 weeks.
  • Data collected included demographics, clinical signs/symptoms, and histopathological findings.
  • Analysis of diagnostic test results (GeneXpert, PPD) and association of lymph node location with diagnoses.

Main Results:

  • Tuberculosis (33.7%) and lymphoma (10.3%) were the most common diagnoses after reactive hyperplasia (40.3%).
  • Cervical lymphadenopathy was most frequent; supraclavicular nodes were linked to lymphoma (p=0.008).
  • Sputum GeneXpert showed a 78.84% true-positive rate for TB; PPD was positive in only 13 TB patients.

Conclusions:

  • Tuberculosis and lymphoma are the leading causes of persistent pediatric lymphadenopathy requiring biopsy.
  • Empiric TB therapy may be considered with positive GeneXpert and clinical suspicion in endemic areas, potentially avoiding biopsy.
  • Excisional biopsy remains the gold standard, but less invasive diagnostic algorithms warrant further research.